Among the 24 patients who tested positive for EGFR-TK, the assessment of tumor expression revealed three (12.5%) with low expression, 13 (54.2%) with moderate expression, and eight (33.3%) with strong expression. This evidence concerns the gene EGFR and neoplasm.